Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Cefminox sodium [JAN]
RN: 75498-96-3
UNII: YNM4DBJ3N8
InChIKey: SBIDXLKJYJVQOE-YNJMIPHHSA-M

Classification Codes

  • Drug / Therapeutic Agent
  • Reproductive Effect

Molecular Formula

  • C16-H21-N7-O7-S3.x-Na

Molecular Weight

  • 541.564
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Cefminox sodium [JAN]

Synonyms

  • Antibiotic MT-141
  • Cefminox sodium
  • Meicelin
  • UNII-YNM4DBJ3N8

Systematic Name

  • 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6R-(6-alpha,7-alpha))-

Registry Numbers

CAS Registry Number

  • 75498-96-3

FDA UNII

  • YNM4DBJ3N8

Other Registry Number

  • 97162-19-1

System Generated Number

  • 0075498963

Molecular Formulas

Molecular Formula

  • C16-H21-N7-O7-S3.x-Na

Molecular Formula Fragments

  • C16-H21-N7-O7-S3
  • COMPONENT
  • Na

Structure Descriptors

InChI

1S/C16H21N7O7S3.Na/c1-22-15(19-20-21-22)33-4-7-3-32-14-16(30-2,13(29)23(14)10(7)12(27)28)18-9(24)6-31-5-8(17)11(25)26;/h8,14H,3-6,17H2,1-2H3,(H,18,24)(H,25,26)(H,27,28);/q;+1/p-1/t8-,14-,16+;/m1./s1

InChIKey

SBIDXLKJYJVQOE-YNJMIPHHSA-M

Smiles

[Na+].CO[C@]1(NC(=O)CSC[C@@H](N)C(=O)O)[C@H]2SCC(=C(N2C1=O)C(=O)[O-])CSc3nnnn3C

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intramuscular 8200mg/kg (8200mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
mouse LD50 intravenous 5200mg/kg (5200mg/kg) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
mouse LD50 oral > 10gm/kg (10000mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 18, Pg. 1030, 1987.
rat LD50 intramuscular 9600mg/kg (9600mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
rat LD50 intraperitoneal 8550mg/kg (8550mg/kg) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
rat LD50 intravenous 5700mg/kg (5700mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
rat LD50 oral > 15gm/kg (15000mg/kg)   Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
rat LD50 subcutaneous > 15gm/kg (15000mg/kg)   Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.